Mentioned in ?
References in periodicals archive ?
1 billion was spent on avoidable medical and pharmacy expenses as a result of patients' nonadherence to medications.
Risk factors for exacerbation identified in prior studies include severe asthma, viral infections, nonadherence to controller medication, tobacco exposure, and possibly fetal sex and maternal body mass index, the investigators said.
In addition, pharmacists working with clinicians to identify and address nonadherence also enhanced patient adherence.
The association between changes in pill appearance and nonadherence to essential cardiovascular medications has important implications for public health," said study co-author Aaron Kesselheim, MD, JD, MPH, assistant professor of medicine at Harvard Medical School and associate physician at Brigham and Women's Hospital.
These are instances which have happened at the lower level, at the branch level because of lack of due diligence or nonadherence to the norms and procedures," he said.
Nearly half of all patients who respond to initial conventional therapies relapse within 2 years, mainly because of high rates of nonadherence, explained Dr.
accomplished health psychology expert specializing in oncology, will discuss the proven techniques for predicting and addressing nonadherence along with effective techniques to drive behavior change
In this cross-sectional telephone interview study, we examined a range of behavioral responses to drug costs, including both potentially cost-saving behaviors, such as switching to generic medications, and potentially adverse behaviors, including cost-related nonadherence and financial stress.
In general, rates of nonadherence have not changed in the past 30 years (Atreja, Bellam, & Levy, 2005).
It adds studies on behavioral issues and encopresis; new prevalence figures; discussion of the role of constipation in encopresis and enuresis; updated information on the long-term health impact of poorly managed pain experiences; new information on factors that contribute to pain; updated discussion of the impact of nonadherence on mental and medical outcomes and the role of the health care provider; and discussion of proposed changes for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders.
kidney-transplantation programs reported that their patients had an 'extremely serious' or 'very serious' problem paying for immunosuppressive medications, and 68% reported deaths and graft losses attributable to cost-related nonadherence.
According to a 2009 report from the New England Healthcare Institute, medication nonadherence accounts for an astonishing $290 billion in otherwise avoidable medical spending per year due to complications from chronic disease.